Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Prof-Hironori-Yoshiyama"

1 News Found

Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
Drug Approval | September 07, 2021

Sharp develops Plasmacluster tech that reduces airborne novel coronavirus

Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained